NCT06049901View on ClinicalTrials.gov

Nitazoxanide in Patients With Metastatic Colorectal Cancer

PHASE3RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

March 31, 2025

Study Completion Date

March 31, 2026

Conditions
Metastatic Colorectal Cancer
Interventions
DRUG

Nitazoxanide

Nitazoxanide is considered a broad-spectrum anti-microbial drug with a potent activity against various helminths, anaerobic bacteria and viruses.

Trial Locations (1)

31527

RECRUITING

Tanta University Hospital, Tanta

All Listed Sponsors
lead

Tanta University

OTHER